Guggenheim Capital’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,448
| Closed | -$291K | – | 1902 |
|
|
2024
Q2 | $291K | Sell |
2,448
-344
| -12% | -$36.2K | ﹤0.01% | 1663 |
|
|
2024
Q1 | $300K | Sell |
2,792
-1,763
| -39% | -$175K | ﹤0.01% | 1664 |
|
|
2023
Q4 | $454K | Sell |
4,555
-495
| -10% | -$48.4K | ﹤0.01% | 1492 |
|
|
2023
Q3 | $601K | Sell |
5,050
-47
| -0.9% | -$7.01K | 0.01% | 1331 |
|
|
2023
Q2 | $908K | Sell |
5,097
-51
| -1% | -$9.36K | 0.01% | 1211 |
|
|
2023
Q1 | $849K | Buy |
5,148
+121
| +2% | +$20.8K | 0.01% | 1261 |
|
|
2022
Q4 | $792K | Buy |
5,027
+742
| +17% | +$113K | 0.01% | 1284 |
|
|
2022
Q3 | $646K | Buy |
4,285
+2,044
| +91% | +$340K | 0.01% | 1366 |
|
|
2022
Q2 | $369K | Buy |
2,241
+463
| +26% | +$89.1K | ﹤0.01% | 1703 |
|
|
2022
Q1 | $396K | Buy |
+1,778
| New | +$398K | ﹤0.01% | 1767 |
|
|
2021
Q2 | – | Sell |
-1,319
| Closed | -$271K | – | 2207 |
|
|
2021
Q1 | $271K | Sell |
1,319
-245
| -16% | -$51.7K | ﹤0.01% | 1993 |
|
|
2020
Q4 | $335K | Sell |
1,564
-1,487
| -49% | -$288K | ﹤0.01% | 1790 |
|
|
2020
Q3 | $558K | Buy |
3,051
+731
| +32% | +$138K | ﹤0.01% | 1410 |
|
|
2020
Q2 | $428K | Sell |
2,320
-300
| -11% | -$59.6K | ﹤0.01% | 1491 |
|
|
2020
Q1 | $529K | Sell |
2,620
-893
| -25% | -$172K | 0.01% | 1348 |
|
|
2019
Q4 | $657K | Buy |
3,513
+1,174
| +50% | +$202K | ﹤0.01% | 1506 |
|
|
2019
Q3 | $373K | Buy |
2,339
+1,150
| +97% | +$229K | ﹤0.01% | 1754 |
|
|
2019
Q2 | $300K | Sell |
1,189
-1,966
| -62% | -$456K | ﹤0.01% | 1865 |
|
|
2019
Q1 | $755K | Sell |
3,155
-3,132
| -50% | -$751K | 0.01% | 1514 |
|
|
2018
Q4 | $1.44M | Sell |
6,287
-1,432
| -19% | -$353K | 0.01% | 1205 |
|
|
2018
Q3 | $2.18M | Sell |
7,719
-1,059
| -12% | -$310K | 0.01% | 1194 |
|
|
2018
Q2 | $2.58M | Sell |
8,778
-41,586
| -83% | -$11.4M | 0.02% | 1095 |
|
|
2018
Q1 | $12.7M | Buy |
50,364
+28,468
| +130% | +$6.69M | 0.03% | 605 |
|
|
2017
Q4 | $4.73M | Buy |
21,896
+12,455
| +132% | +$2.52M | 0.01% | 1066 |
|
|
2017
Q3 | $1.75M | Sell |
9,441
-493
| -5% | -$86K | ﹤0.01% | 1763 |
|
|
2017
Q2 | $1.71M | Sell |
9,934
-105
| -1% | -$16.8K | ﹤0.01% | 1742 |
|
|
2017
Q1 | $1.53M | Sell |
10,039
-944
| -9% | -$138K | ﹤0.01% | 1837 |
|
|
2016
Q4 | $1.62M | Sell |
10,983
-94
| -0.8% | -$13.6K | ﹤0.01% | 1838 |
|
|
2016
Q3 | $1.4M | Sell |
11,077
-8,487
| -43% | -$1.02M | ﹤0.01% | 1860 |
|
|
2016
Q2 | $2.21M | Sell |
19,564
-652
| -3% | -$67.7K | 0.01% | 1502 |
|
|
2016
Q1 | $2.1M | Sell |
20,216
-1,759
| -8% | -$168K | 0.01% | 1536 |
|
|
2015
Q4 | $2.48M | Sell |
21,975
-111
| -0.5% | -$12.3K | 0.01% | 1457 |
|
|
2015
Q3 | $2.42M | Sell |
22,086
-8,473
| -28% | -$906K | 0.01% | 1463 |
|
|
2015
Q2 | $2.92M | Sell |
30,559
-2,115
| -6% | -$198K | 0.01% | 1472 |
|
|
2015
Q1 | $3.04M | Sell |
32,674
-3,406
| -9% | -$298K | 0.01% | 1454 |
|
|
2014
Q4 | $2.96M | Buy |
36,080
+11,108
| +44% | +$852K | 0.01% | 1446 |
|
|
2014
Q3 | $1.6M | Buy |
24,972
+19,650
| +369% | +$1.2M | ﹤0.01% | 1934 |
|
|
2014
Q2 | $324K | Sell |
5,322
-836
| -14% | -$49.4K | ﹤0.01% | 2744 |
|
|
2014
Q1 | $369K | Sell |
6,158
-332
| -5% | -$20.5K | ﹤0.01% | 2682 |
|
|
2013
Q4 | $413K | Sell |
6,490
-6,666
| -51% | -$429K | ﹤0.01% | 2615 |
|
|
2013
Q3 | $894K | Buy |
13,156
+2,341
| +22% | +$167K | ﹤0.01% | 2156 |
|
|
2013
Q2 | $779K | Buy |
+10,815
| New | +$715K | ﹤0.01% | 2191 |
|
Other funds holding ICUI
Guggenheim Capital's ICUI Position: Q3 2024 in Review
Guggenheim Capital sold out of ICU Medical (ICUI) in Q3 2024, closing a stake of 2,448 shares — an estimated $291K sold.
Guggenheim Capital first reported a position in ICUI in Q2 2013 and held it in 42 quarters. The position peaked at $12.7M in Q1 2018. 289 funds tracked by Wall St. Rank hold ICUI as of Q3 2024.
- Guggenheim Capital reported no remaining ICU Medical position as of Q3 2024 after selling out during the quarter.
- Guggenheim Capital sold 2,448 ICU Medical shares in Q3 2024, an estimated $291K.
- Guggenheim Capital first reported a position in ICU Medical in Q2 2013 and held it in 42 quarters.
- Guggenheim Capital's ICU Medical position peaked at $12.7M in Q1 2018.
- 289 funds tracked by Wall St. Rank held ICU Medical as of Q3 2024.
Based on Guggenheim Capital's 13F filing for Q3 2024, filed 13 Nov 2024.